Linked research, clinical, and regulatory source pathways.
Company profile
About Inovalon
Inovalon is a healthcare technology company that delivers data-driven software and analytics solutions across the healthcare ecosystem. The company brings together national-scale connectivity, real-time primary source data access, and advanced analytics to power solutions that enable improved clinical outcomes and economics. Inovalon serves four primary markets: health payers (helping improve member care and outcomes with sophisticated analytics), healthcare providers (optimizing revenue cycle management, care quality management, and workforce management), pharmacies (streamlining operations with automated processing and real-time data exchange), and life sciences organizations (providing real-world data and insights for clinical trials, HEOR, and commercial analytics). The company's comprehensive suite includes quality measurement solutions (Best in KLAS rated), risk score accuracy tools, member outreach platforms, value-based care management systems, revenue cycle management software, and specialty pharmacy management solutions. Inovalon's Healthcare Data Lake serves as a single source of truth for storing, enriching, and analyzing healthcare data. The company is trusted by all of the top 25 U.S. provider systems and has won recognition including the MedTech Breakthrough Award for Best Revenue Cycle Management Solutions. Inovalon's mission centers on giving data a voice to drive meaningful change in patient outcomes, business performance, and healthcare economics.
Company description Inovalon official website
Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Inovalon?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Health Systems
- Life Sciences
- Payers
- Pharmacies
- Providers
- Specialty Pharmacies
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsUSA
Company sourceOfficial website
Company milestones
Platform expansion
Won MedTech Breakthrough Award for Best Revenue Cycle Management Solutions; achieved Best in KLAS rating for Quality Measurement solution; trusted by all top 25 U.S. provider systems
Partnerships
Recorded partners
- Aetna/CVS Health
- Ardon Health
- PAM Health
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Invasive pneumococcal disease in Latin America: serotype distribution and vaccine coverage among adults in Mexico, Brazil, and Argentina.Vaccine · Jul 31, 2026
Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs.Rheumatology and therapy · Jul 24, 2026
Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes.The journal of allergy and clinical immunology. In practice · Jun 12, 2026
Changes in persistence to basal insulin following the Medicare out-of-pocket cost cap.The American journal of managed care · Jun 1, 2026
Outcomes of patients with COPD before and after initiation of treatment with budesonide/glycopyrrolate/formoterol fumarate: Results from the US ARCTOS study.Respiratory medicine · Jun 1, 2026
Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic Therapy.PharmacoEconomics - open · May 1, 2026
Clinical validation
Clinical-trial records
Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe ExacerbationNCT07414134 · Mentioned · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Best in KLAS Quality Measurement
For health plan quality teams
Denial reductions and ROI gains
Revenue cycle management
Decreased time to fill and cost to serve
Specialty pharmacy operations
Improved medication adherence
Pharmacy management with ML-powered predictions
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Inovalon
Recent articles published on Inovalon's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Population Health & Healthcare Analytics
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.